Powell Industries vs Vir Biotechnology Inc. Common Stock — how do they compare? Powell Industries trades at $164.99 (market cap $6.18B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Powell Industries is far larger — about 3.5× Vir Biotechnology Inc. Common Stock's market cap, and Powell Industries pays a 0.21% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Powell Industries for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| POWL | VIR | |
|---|---|---|
Market Cap | $6.18B | $1.76B |
Volume | 1,083,698 | 2,764,948 |
Sector | Industrials | Health |
52-Week High | $322.05 | $11.78 |
52-Week Low | $94.02 | $5.12 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $5.55B | $1.32B |
Dividend Yield | 0.21% | — |
Signals from Pluang's Aura AI — not financial advice
Powell Industries (POWL) trades at $182.79, down 1.4% with bearish technical signals. The company shows strong profitability with 16.49% net margin and 28.25% ROE, though recent quarters missed earnings estimates. Analyst consensus is mixed with 30% buy ratings but a $284 price target suggesting 55% upside. The stock faces near-term pressure from technical weakness despite solid fundamentals and a $2.4 billion backlog supporting future growth.
The investment case balances strong operational performance against technical headwinds. Upside potential exists from backlog conversion and capacity expansion, but risks include execution challenges and market volatility. With valuation metrics elevated (P/E 34.99), successful earnings delivery in upcoming quarters remains critical for sustaining investor confidence and achieving analyst targets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →